Merimepodib

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated, ViralClear Pharmaceuticals, Inc.

Conditions

COVID-19HepatitisHepatitis C

Phase 2

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

CompletedNCT00088504

Vertex Pharmaceuticals IncorporatedHepatitis, Hepatitis C

Start: 2004-07-31End: 2006-10-31Target: 315Updated: 2007-12-21

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

TerminatedNCT04410354

ViralClear Pharmaceuticals, Inc.COVID-19

Start: 2020-06-16End: 2020-12-01Updated: 2020-12-08